Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 60,000 shares at $28.01 ($1.7M) on 2016-04-14, disclosed to the SEC on 2016-04-18.
Open-market sale of $1.7M ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.01 | 11,462 | $321K | 19.1% |
| 2 | $28.01 | 11,462 | $321K | 19.1% |
| 3 | $28.11 | 14,024 | $394K | 23.4% |
| 4 | $28.11 | 14,024 | $394K | 23.4% |
| 5 | $28.08 | 4,514 | $127K | 7.5% |
| 6 | $28.08 | 4,514 |
| $127K |
| 7.5% |
| Total | $28.07 avg | 60,000 | $1.7M | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |